These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 34764039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Leleu O, Basille D, Auquier M, Clarot C, Hoguet E, Pétigny V, Addi AA, Milleron B, Chauffert B, Berna P, Jounieaux V.
    Clin Lung Cancer; 2020 Mar; 21(2):145-152. PubMed ID: 31982356
    [Abstract] [Full Text] [Related]

  • 3. Lung cancer screening by low-dose CT scan in France: final results of the DEP KP80 study after three rounds.
    Leleu O, Storme N, Basille D, Auquier M, Petigny V, Berna P, Letierce A, Couraud S, de Bermont J, Milleron B, Jounieaux V.
    EBioMedicine; 2024 Nov; 109():105396. PubMed ID: 39396424
    [Abstract] [Full Text] [Related]

  • 4. Predictive factors for the participation of general practitioners in lung cancer screening by low-dose CT scan in the Somme department in northern France.
    Leleu O, Vincent G, Auquier M, Basille D, Clarot C, Hoguet E, Pétigny V, Duban P, Zerkly S, Ganry O, Chauffert B, Berna P, Jounieaux V.
    Respir Med Res; 2020 Mar; 77():95-99. PubMed ID: 32512523
    [Abstract] [Full Text] [Related]

  • 5. Epidemiological impact of lung cancer screening by low dose CT scan in the French Department of the SOMME.
    Addi AA, Leleu O, Basille D, Lapôtre-Ledoux B, Auquier M, Ganry O, Berna P, Jounieaux V.
    Respir Med Res; 2022 May; 81():100887. PubMed ID: 35219227
    [Abstract] [Full Text] [Related]

  • 6. Behavior of general physicians about lung cancer screening in a French region hosting a pilot study.
    Marchal E, Burgaud C, Jounieaux V, Leleu O.
    Respir Med Res; 2023 Jun; 83():100992. PubMed ID: 36812773
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ.
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
    Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.
    Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640
    [Abstract] [Full Text] [Related]

  • 14. Cost of screening for lung cancer in Australia.
    Marshall HM, Finn N, Bowman RV, Passmore LH, McCaul EM, Yang IA, Connelly L, Fong KM.
    Intern Med J; 2019 Nov; 49(11):1392-1399. PubMed ID: 31336016
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study.
    Yannoutsos A, Fontaine M, Galloula A, Damotte D, Chatellier G, Paterlini-Bréchot P, Meyer G, Pastre J, Duchatelle V, Marini V, Schwering KL, Lazareth I, Ghaffari P, Stansal A, Sanson H, Labrousse C, Beaussier H, Nasr NB, Zins M, Salmeron S, Messas E, Lajonchère JP, Emmerich J, Priollet P, Trédaniel J.
    BMC Cardiovasc Disord; 2019 Sep 13; 19(1):212. PubMed ID: 31519196
    [Abstract] [Full Text] [Related]

  • 17. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH, Boutros J, Benzaquen J, Ferreira M, Pastre J, Pison C, Padovani B, Bettayeb F, Fallet V, Guibert N, Basille D, Ilie M, Hofman V, Hofman P, AIR project Study Group.
    Lancet Respir Med; 2020 Jul 13; 8(7):709-716. PubMed ID: 32649919
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC, Schmidt H, Martel S, McWilliams A, Goffin JR, Johnston MR, Nicholas G, Tremblay A, Bhatia R, Liu G, Soghrati K, Yasufuku K, Hwang DM, Laberge F, Gingras M, Pasian S, Couture C, Mayo JR, Nasute Fauerbach PV, Atkar-Khattra S, Peacock SJ, Cressman S, Ionescu D, English JC, Finley RJ, Yee J, Puksa S, Stewart L, Tsai S, Haider E, Boylan C, Cutz JC, Manos D, Xu Z, Goss GD, Seely JM, Amjadi K, Sekhon HS, Burrowes P, MacEachern P, Urbanski S, Sin DD, Tan WC, Leighl NB, Shepherd FA, Evans WK, Tsao MS, Lam S, PanCan Study Team.
    Lancet Oncol; 2017 Nov 13; 18(11):1523-1531. PubMed ID: 29055736
    [Abstract] [Full Text] [Related]

  • 20. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan.
    Nawa T, Fukui K, Nakayama T, Sagawa M, Nakagawa T, Ichimura H, Mizoue T.
    Jpn J Clin Oncol; 2019 Feb 01; 49(2):130-136. PubMed ID: 30541133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.